Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR) - Judge, D P; Kristen, A V; Grogan, M (Cardiovasc Drugs Ther, 2020)